These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19760962)

  • 1. A novel method for preparing microbubbles targeting hepatocellular carcinoma.
    Liu F; Wang X; Yang L; Jiang B
    Hepatogastroenterology; 2009; 56(93):1163-8. PubMed ID: 19760962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting vascular endothelium with avidin microbubbles.
    Korpanty G; Grayburn PA; Shohet RV; Brekken RA
    Ultrasound Med Biol; 2005 Sep; 31(9):1279-83. PubMed ID: 16176794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buoyancy-activated cell sorting using targeted biotinylated albumin microbubbles.
    Liou YR; Wang YH; Lee CY; Li PC
    PLoS One; 2015; 10(5):e0125036. PubMed ID: 25993512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of vaccinia virus using biotin-avidin viral coating and biotinylated antibodies.
    Purow B; Staveley-O'Carroll K
    J Surg Res; 2005 Jan; 123(1):49-54. PubMed ID: 15652950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic engineering, expression, and activity of a chimeric monoclonal antibody-avidin fusion protein for receptor-mediated delivery of biotinylated drugs in humans.
    Boado RJ; Zhang Y; Zhang Y; Xia CF; Wang Y; Pardridge WM
    Bioconjug Chem; 2008 Mar; 19(3):731-9. PubMed ID: 18278853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes.
    Dinauer N; Balthasar S; Weber C; Kreuter J; Langer K; von Briesen H
    Biomaterials; 2005 Oct; 26(29):5898-906. PubMed ID: 15949555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of luteinising-hormone releasing hormone nanoliposomal microbubbles specifically targeting ovarian cancer cells in vitro.
    Zhang J; Liu S; Zhu Y; Zhang L; Li W; Wang F; Huang S
    Mol Med Rep; 2014 Jul; 10(1):567-71. PubMed ID: 24805264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable nanoparticles for direct or two-step tumor immunotargeting.
    Nobs L; Buchegger F; Gurny R; Allémann E
    Bioconjug Chem; 2006; 17(1):139-45. PubMed ID: 16417262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation and characterization of biotinylated chitosan nanoparticles].
    Yao Q; Hou SX; Zhang X; Zhao G; Gou XJ; You JZ
    Yao Xue Xue Bao; 2007 May; 42(5):557-61. PubMed ID: 17703783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells.
    Nakano K; Orita T; Nezu J; Yoshino T; Ohizumi I; Sugimoto M; Furugaki K; Kinoshita Y; Ishiguro T; Hamakubo T; Kodama T; Aburatani H; Yamada-Okabe H; Tsuchiya M
    Biochem Biophys Res Commun; 2009 Jan; 378(2):279-84. PubMed ID: 19022220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of lipid microbubbles targeted to alpha(v)beta(3)-integrin via biotin-avidin bridge.
    Wang W; Liu GJ; Xie XY; Xu ZF; Chen LD; Huang GL; Zhou LY; Lu MD
    J Microencapsul; 2012; 29(2):177-84. PubMed ID: 22126316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of NADPH-cytochrome P450 reductase antisense oligos using avidin-biotin approach.
    Pillai VC; Yesudas R; Shaik IH; Thekkumkara TJ; Bickel U; Srivenugopal KS; Mehvar R
    Bioconjug Chem; 2010 Feb; 21(2):203-7. PubMed ID: 20063878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of perfluorocarbon microbubbles to selective populations of circulating blood cells.
    Simberg D; Mattrey R
    J Drug Target; 2009 Jun; 17(5):392-8. PubMed ID: 19505207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion and ultrasound-induced delivery from monodisperse microbubbles in a parallel plate flow cell.
    Schmidt BJ; Sousa I; van Beek AA; Böhmer MR
    J Control Release; 2008 Oct; 131(1):19-26. PubMed ID: 18639595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of instantaneous uniformity of SonoVue microbubbles on binding characteristics of a new contrast agent targeted to choriocarcinoma cells in vitro].
    Zhou LX; Ding H; Jia CX; Li Y; Wei Q
    Ai Zheng; 2008 Jul; 27(7):692-7. PubMed ID: 18606060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties.
    Baglioni M; Fiume L; Bolondi L; Farina C; Kratz F; Di Stefano G
    Dig Liver Dis; 2008 Dec; 40(12):963-4. PubMed ID: 18606580
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatocellular carcinoma metastatic to skin: diagnostic utility of antihuman hepatocyte antibody in combination with albumin in situ hybridization.
    Wood AJ; Lappinga PJ; Ahmed I
    J Cutan Pathol; 2009 Feb; 36(2):262-6. PubMed ID: 18727662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioconjugation of biotinylated PAMAM dendrons to avidin.
    Tao L; Geng J; Chen G; Xu Y; Ladmiral V; Mantovani G; Haddleton DM
    Chem Commun (Camb); 2007 Sep; (33):3441-3. PubMed ID: 17700875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of epirubicin-loaded lipid microbubbles with conjugated anti-ABCG2 antibody combined with therapeutic ultrasound on multiple myeloma cancer stem cells.
    Shi F; Yang F; He X; Zhang Y; Wu S; Li M; Zhang Y; Di W; Dou J; Gu N
    J Drug Target; 2016; 24(1):34-46. PubMed ID: 26204324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope mapping of series of monoclonal antibodies against the hepatocellular carcinoma-associated antigen HAb18G/CD147.
    Ku XM; Liao CG; Li Y; Yang XM; Yang B; Yao XY; Wang L; Kong LM; Zhao P; Chen ZN
    Scand J Immunol; 2007 May; 65(5):435-43. PubMed ID: 17444954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.